Evidence map›Paper›PMID 33723339›Full record

ArticleScientific reports2021

Author Correction: Cytoskeletal disorganization underlies PABPN1-mediated myogenic disability.

Cyriel Sebastiaan Olie, Erik van der Wal, Domagoj Cikes, Loes Maton, Jessica C de Greef, I-Hsuan Lin, Yi-Fan Chen, Elsayad Kareem, Josef M Penninger, Benedikt M Kessler and 1 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Cyriel Sebastiaan OlieHuman Genetics Department, Leiden University Medical Center, Leiden, The Netherlands.
Erik van der WalHuman Genetics Department, Leiden University Medical Center, Leiden, The Netherlands.
Domagoj CikesIMBA-Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Loes MatonHuman Genetics Department, Leiden University Medical Center, Leiden, The Netherlands.
Jessica C de GreefHuman Genetics Department, Leiden University Medical Center, Leiden, The Netherlands.
I-Hsuan LinVYM Genome Research Center, National Yang-Ming University, Taipei, Taiwan.
Yi-Fan ChenCollege of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Elsayad KareemAdvanced Microscopy Facility, Vienna Biocenter Core Facilities, Vienna Biocenter (VBC), Vienna, Austria.
Josef M PenningerIMBA-Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Benedikt M KesslerTarget Discovery Institute, Nuffield, Department of Medicine, University of Oxford, Oxford, UK.
Vered RazHuman Genetics Department, Leiden University Medical Center, Leiden, The Netherlands. V.Raz@lumc.nl.
Leiden University Medical Center · NLAustrian Academy of Sciences · ATInstitute of Molecular Biotechnology · ATNational Yang Ming Chiao Tung University · TWTaipei Medical University · TWUniversity of Oxford · GBVienna Biocenter · AT

Funding

Medical Research Council G0501068
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33723339
PMCPMC7961016
OpenAlexW3137053086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.